Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/18676833

Cancer Res. 2008 Aug 1 68 15 6109-17

Download in:

View as

General Info

PMID
18676833